• About Us
  • Board of Directors
  • History
  • Our Mission
  • Park Team
• Facilities
  • National Research Council
  • Windermere Manor
  • Mogenson Building
  • The Convergence Centre
  • Stiller Centre
• Affiliated Parks
  • Advanced Manufacturing Park
  • Western Sarnia-Lambton Research Park
• Tenant Inquiries
  • Available Space Listing
  • Tenant Listing
• News and Events
  • News
  • Events

• Home
• News and Events

News

May 09, 2013

Sernova Provides Corporate Update and Results of 2013 Annual General Meeting


May 06, 2013

Artificial Intelligence-Based Technology Yielding Positive Results in Drug Discovery Collaborations


April 30, 2013

Western Announces Paul Paolatto as Next Executive Director of Western Research Parks


April 29, 2013

OGI's Early Stage Investment in Cytognomix Contributes to the Success of the Shannon Human Splicing Pipeline


April 26, 2013

Additional U.S. Patents for Lead Cancer Drug Candidate Strengthen Critical Outcome's Investment Proposition


April 19, 2013

Critical Outcome Technologies Inc. Presenting at the 2013 Bio International Convention


April 09, 2013

Critical Outcome Technologies Inc. Provides Important Update on AML Program


April 05, 2013

Sernova Issues Additional Finder Warrants, Cancels Options


April 02, 2013

Critical Outcome Technologies Inc. Retains Market-Making Services


March 28, 2013

Critical Outcome Technologies Inc. Reports Fiscal 2013 Third Quarter Financial Results


March 25, 2013

Sernova Awarded Funding to Optimize Its Sertolin(TM) Local Therapeutic Cell Anti-Rejection Technology for the Treatment of Chronic Diseases


February 28, 2013

Sernova and Centre for Commercialization of Regenerative Medicine Partner to Treat Chronic Diseases


February 19, 2013

Sernova Completes Non-Brokered Private Placement


January 31, 2013

Critical Outcome Technologies Inc. Completes Financing


January 21, 2013

Sernova Announces Non-Brokered Private Placement


January 09, 2013

2013 Venture London Business Competition


December 13, 2012

COTI-2 Found to Correct Specific p53 Gene Mutation in Human Ovarian Cancer Cells


December 06, 2012

Critical Outcome Technologies Inc. Announces Drug Discovery Agreement With Multinational Pharmaceutical Company


December 04, 2012

Sernova's Novel Method Evaluates Islets Prior to Transplantation and Predicts Their Ability to Reverse Diabetes Post Transplantation


November 06, 2012

Promising Results from HIV Vaccine Trials


November 05, 2012

FedDev Pumping $13M into London Fraunhofer Project Centre